Plasma growth differentiation factor 15: a novel tool to detect early changes of hereditary transthyretin amyloidosis

Plasma growth differentiation factor 15: a novel tool to detect early changes of hereditary transthyretin amyloidosis

Abstract Aims Hereditary transthyretin (ATTRv) amyloidosis is the most frequent and representative form of autosomal dominant hereditary systemic amyloidosis. Disease‐modifying treatments of the disease are more effective during the early stages, and we require biomarkers to detect early pathologica...

Full description

Bibliographic Details
Main Authors: Masamitsu Okada, Yohei Misumi, Teruaki Masuda, Seiji Takashio, Masayoshi Tasaki, Hiroaki Matsushita, Akihiko Ueda, Yasuteru Inoue, Toshiya Nomura, Makoto Nakajima, Taro Yamashita, Satoru Shinriki, Hirotaka Matsui, Kenichi Tsujita, Yukio Ando, Mitsuharu Ueda
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:ESC Heart Failure
Subjects:
Amyloidosis
Hereditary transthyretin amyloidosis
Asymptomatic mutation carrier
Growth differentiation factor 15
Online Access:https://doi.org/10.1002/ehf2.13176

Internet

https://doi.org/10.1002/ehf2.13176

Similar Items